News
PFE
27.11
-0.84%
-0.23
Mixed options sentiment in Pfizer with shares down 0.79%
TipRanks · 6h ago
MRK, Daiichi's BLA for ADC Drug Gets FDA Priority Tag in Lung Cancer
NASDAQ · 10h ago
Analysts Offer Insights on Healthcare Companies: Avita Medical (RCEL) and Pfizer (PFE)
TipRanks · 12h ago
Investing $8,000 In Each of These 3 Stocks in 2026 Could Generate $1,500 in Annual Dividends
The Motley Fool · 12h ago
Earnings Preview: What to Expect From Pfizer’s Report
Barchart · 16h ago
If You Believe In AI Healthcare, Then This Trio Could Shape Your Next Cycle Of Exposure
Simply Wall St · 1d ago
Pfizer Is Maintained at Neutral by UBS
Dow Jones · 1d ago
UBS Maintains Neutral on Pfizer, Raises Price Target to $27
Benzinga · 1d ago
My Top 4 Pharma Picks Under Rising Geopolitical Risk
Seeking Alpha · 1d ago
Mixed options sentiment in Pfizer with shares down 0.28%
TipRanks · 1d ago
Pfizer price target raised to $27 from $25 at UBS
TipRanks · 1d ago
Dividend Harvesting Portfolio Week 267: $26,700 Allocated, $2,927.54 In Projected Dividends
Seeking Alpha · 1d ago
Analysts Are Bullish on Top Healthcare Stocks: InflaRx (IFRX), Pfizer (PFE)
TipRanks · 1d ago
Wells Fargo Releases a Hold Rating on Pfizer (PFE)
TipRanks · 1d ago
Elon Musk Questions COVID-19 Vaccine Dosage, Says It Was 'Obviously Too High'
Benzinga · 1d ago
Weekly Report: what happened at PFE last week (0406-0410)?
Weekly Report · 1d ago
Notable healthcare headlines for the week: Organon, Eli Lilly, and Gilead in focus
Seeking Alpha · 2d ago
Better Buy Right Now: Johnson & Johnson Vs. Pfizer
The Motley Fool · 2d ago
Pfizer Stock Stalls As Pipeline Bets Grow
TipRanks · 3d ago
Pfizer told by FDA that Facebook ads for Adcetris ‘false or misleading’
TipRanks · 4d ago
More
Webull provides a variety of real-time PFE stock news. You can receive the latest news about Pfizer through multiple platforms. This information may help you make smarter investment decisions.
About PFE
Pfizer Inc. is a research-based, global biopharmaceutical company. The Company is engaged in the discovery, development, manufacture, marketing, sale and distribution of biopharmaceutical products worldwide. Its Biopharma segment includes the Pfizer U.S. Commercial Division, and the Pfizer International Commercial Division. Its product categories include oncology, primary care and specialty care. Its oncology products include Ibrance, Xtandi, Padcev, Adcetris, Inlyta, Lorbrena, Bosulif, Tukysa, Braftovi, Mektovi, Orgovyx, Elrexfio, Tivdak and Talzenna. Its primary care products include Eliquis, Nurtec ODT/Vydura, Zavzpret, the Prevnar family, Comirnaty, Abrysvo, FSME/IMMUN-TicoVac, Nimenrix, Trumenba, and Paxlovid. Its specialty care products include Xeljanz, Enbrel (outside the United States and Canada), Inflectra, Abrilada, Cibinqo, Litfulo, Eucrisa, Velsipity, the Vyndaqel family, Genotropin, and others. Its PF-08653944 is an ultra-long-acting fully biased GLP-1 receptor agonist.